Search
for
Sort by
Research 871–900 of 1000+
- POLYCYSTIC OVARY SYNDROME: DIVERSE CLINICAL PRESENTATIONS ACROSS ADOLESCENCE, REPRODUCTIVE AGE, AND MENOPAUSE
- A Bibliometric Analysis of Alopecia Areata Literature over the Past 50 Years.
- Valproate-Associated Transaminitis and Rhabdomyolysis
- Treatment of Frontal Fibrosing Alopecia in Black Patients: A Systematic Review
- Results of low‐level laser therapy in the treatment of hair growth: An Egyptian experience
- Platelet‐rich plasma with low dose oral minoxidil (1.25mg versus 2.5mg) along with trichoscopic pre‐ and post‐treatment evaluation
- Alopecia areata universalis nach Sitagliptin-Einnahme
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- Biotin
- Dermatologic Adverse Events from Cancer Treatments
- Topical Valproate Solution for Hair Growth
- Effects of 5-alpha reductase inhibitors
- Debatable Topics in PCOS Patients
- Management of Toxicities of Targeted Therapies
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Update on Frontal Fibrosing Alopecia
- Primary Care of Adult Women
- Current and future pharmacotherapy for alopecia areata
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Nonclassic congenital adrenal hyperplasia and the heterozygote carrier
- Acne
- Acne and acneiform eruptions
- An Update on Scalp Psoriasis
- Hair Growth After Gefitinib Treatment
- Cardiac biopsy in myocarditis
- Effectiveness of Radiofrequency Microneedling in the Treatment of Dermatological Conditions: A Systematic Review
- ROS-scavenging microneedles loaded with <i>Portulaca oleracea</i> L.-derived exosomes for atopic dermatitis therapy
- The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis
- Urinary steroid metabolome shows adrenal, gonadal, and neuroactive steroid dysregulation in adolescents with depression
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies